Dr B Robert Mozayeni - Persistent Bartonella infection

CRYPTO-INFECTIONS CONFERENCE 2023
LYME DISEASE & OTHER HIDDEN INFECTIONS: MICROBIAL PERSISTENCE
The Third international ‘CryptoConference’ was held in Dublin Ireland June 17th to 18th 2023. ‘Crypto’ refers to occult infections which are hard to diagnose and hard to treat. The theme of the third conference is ‘microbial persistence’, which is the way that these occult infections evade the immune system and evade routine diagnostic techniques. We invited a range of clinicians and basic scientists from the USA, Canada, and throughout the European Union, to spend two days in Dublin. The topics to be addressed include Borrelia, Bartonella, Babesia, and a range of other microbial pathogens. Lectures provided will appeal to primary care doctors (general practitioners) on the subject of Lyme and Long COVID, as well as more basic science lectures that will appeal to bench researchers as well as clinicians.
Dr B Robert Mozayeni, MD
Expert in Translational Medicine, the science and art of advancing medical science safely and efficiently
Dr. Mozayeni trained in Internal Medicine, Rheumatology and Molecular Biophysics in a physician-scientist research residency at Yale-New Haven Hospital, where Lyme disease was discovered and treated by Rheumatologists in the Rheumatology section. He subsequently became a Senior Staff Fellow at the National Institutes of Health (NIH) where he completed a second fellowship in Rheumatology. Since 1994, while in private practice, has held clinical privileges at Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the NIH Clinical Center.
Recently, he became the President of ILADS. His main objective with ILADS is the same as with his professional career - to advance the science of translational medicine and learn from the issues presented by Lyme disease, how to more rapidly advance medical science. His career passion is to find the fastest path for advancing medical science in diverse areas of patient need and controversy to validate and continuously improve best clinical practices.
He is the Chief Medical Officer of Galaxy Diagnostics, LLC. Recently, he founded ‘T Lab’ focusing on the use of high resolution microscopy to identify cryptic infections and demonstrate how they cause disease. He is a Fellow of the non-profit Think Lead Innovate Foundation and he is a founder of the non-profit Foundation for the Study of Inflammatory Diseases.
His work on cerebrovascular diseases, as a Rheumatologist, he began to appreciate the importance of Bartonella cryptic infections. Over the past 12 years, he has been actively researching chronic rheumatic and cerebrovascular diseases and their relationship to persistent human Bartonella infection.